We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+594.2%
AUM
$42.6B
AUM Growth
+$3.92B
Cap. Flow
+$2.21B
Cap. Flow %
5.18%
Top 10 Hldgs %
21.94%
Holding
6,155
New
1,425
Increased
1,766
Reduced
1,669
Closed
1,261

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.27%
2 Technology 2.76%
3 Financials 1.86%
4 Healthcare 1.62%
5 Communication Services 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRD
4726
Opus Genetics
IRD
$287M
$19K ﹤0.01%
+276
New +$24.3K
HLTH
4727
DELISTED
Nobilis Health Corp.
HLTH
$19K ﹤0.01%
+15,659
New +$21.7K
PAVM icon
4728
PAVmed
PAVM
$36.5M
$17K ﹤0.01%
+39
New +$23.8K
CYTR
4729
DELISTED
CytRx Corp
CYTR
$17K ﹤0.01%
+15,428
New +$23.1K
AST
4730
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$16K ﹤0.01%
+12,051
New +$18.5K
VVUS
4731
DELISTED
Vivus Inc
VVUS
$15K ﹤0.01%
+2,168
New +$13.1K
OPTT icon
4732
Ocean Power Technologies
OPTT
$41.5M
$14K ﹤0.01%
+832
New +$18.4K
AUMN
4733
DELISTED
Golden Minerals Company
AUMN
$13K ﹤0.01%
1,490
-90
-6% -$893
GENE
4734
DELISTED
Genetic Technologies Ltd.
GENE
$13K ﹤0.01%
639
-37
-5% -$875
CANF
4735
Can-Fite BioPharma American Depositary Shares
CANF
$6.77M
$12K ﹤0.01%
+3
New +$12K
MTNB icon
4736
Matinas BioPharma
MTNB
$1.91M
$12K ﹤0.01%
+552
New +$15.9K
EGO icon
4737
Eldorado Gold
EGO
$8.33B
$11K ﹤0.01%
2,219
-36,895
-94% -$190K
ENVB icon
4738
Enveric Biosciences
ENVB
$5.36M
0
IPAS
4739
DELISTED
Ipass Inc Common Stock
IPAS
$11K ﹤0.01%
+3,229
New +$11.9K
QCLS
4740
Q/C Technologies Inc
QCLS
$19.7M
0
WWR icon
4741
Westwater Resources
WWR
$49.7M
$8K ﹤0.01%
+418
New +$10.1K
CEI
4742
DELISTED
Camber Energy, Inc
CEI
0
NEON icon
4743
Neonode
NEON
$12.6M
$7K ﹤0.01%
+1,964
New +$7.84K
GPUS
4744
Hyperscale Data Inc
GPUS
$52.9M
0
EGLT
4745
DELISTED
Egalet Corporation
EGLT
$6K ﹤0.01%
+14,291
New +$7.95K
SDRL
4746
DELISTED
Seadrill Limited Common Stock
SDRL
$3K ﹤0.01%
57
-358
-86% -$33K
ABM icon
4747
ABM Industries
ABM
$2.89B
-6,629
Closed -$222K
ACAD icon
4748
PUT
Acadia Pharmaceuticals
ACAD
$4.51B
-9,600
Closed -$216K
ACWI icon
4749
CALL
iShares MSCI ACWI ETF
ACWI
$32B
-21,200
Closed -$1.52M
ADAP
4750
DELISTED
Adaptimmune Therapeutics
ADAP
-14,947
Closed -$168K

Similar funds

Jane Street's Q2 2018 Portfolio in Review

As of Q2 2018, Jane Street held 6,155 positions worth $42.6B, up 10% from $38.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jane Street deployed $2.21B of net new capital in Q2 2018, opening 1,425 new positions and adding to 1,766 existing holdings. Its largest new stake was iShares MSCI EAFE Growth ETF: 330,065 shares worth $26M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.3% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $381M trimmed.

  • Jane Street's largest Q2 2018 buy was iShares MSCI EAFE Growth ETF: 330,065 shares worth $26M.
  • Jane Street added most to iShares Core MSCI Emerging Markets ETF in Q2 2018, an estimated $277M increase.
  • Jane Street's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $381M.
  • Jane Street fully exited iShares MBS ETF in Q2 2018, selling an estimated $136M.
  • Jane Street's ten largest holdings make up 22% of its $42.6B portfolio in Q2 2018.
  • Jane Street opened 1,425 new positions and closed 1,261 in Q2 2018.
  • Jane Street's portfolio value rose 10% quarter-over-quarter to $42.6B.

Based on Jane Street's 13F filing for Q2 2018, filed 15 Aug 2018.